1186663-16-0

Basic information

• Product Name: 1-(3,4-Difluorophenyl)cyclopropylamine Hydrochloride
• Synonyms: 1-(3,4-Difluorophenyl)cyclopropylamine Hydrochloride;1-(3,4-difluorophenyl)cyclopropanamine;1-(3,4-difluorophenyl)cyclopropanaMine hydrochloride;1-(3,4-DIFLUOROPHENYL)CYCLOPROPYLAMINE HCL
• CAS NO: 1186663-16-0
• Molecular Formula: C9H10ClF2N
• Molecular Weight: 205.6322064
• Product Categories: Amines and Anilines
• Mol File: 1186663-16-0.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(3,4-Difluorophenyl)cyclopropylamine Hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3,4-Difluorophenyl)cyclopropylamine Hydrochloride(1186663-16-0)
• EPA Substance Registry System: 1-(3,4-Difluorophenyl)cyclopropylamine Hydrochloride(1186663-16-0)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 1186663-16-0(Hazardous Substances Data)

Usage

General Description

1-(3,4-Difluorophenyl)cyclopropylamine Hydrochloride is a chemical compound that is a hydrochloride salt of a cyclopropylamine derivative. It is a cyclopropylamine compound which contains a difluorophenyl group. It is commonly used in the synthesis of pharmaceutical drugs and as a reactant in chemical reactions. This chemical may have potential applications in the treatment of various medical conditions, although further research is needed to determine its exact uses and potential benefits. Additionally, it is important to handle this compound with care, as it may have hazardous properties and requires proper handling for safe use.

Upstream product

• 64248-62-0 3,4-Difluorobenzonitrile 
• 925-90-6 ethylmagnesium bromide 

Relevant articles and documents

Oxadiazole Amine Derivative Compounds as Histone Deacetylase 6 Inhibitor, and the Pharmaceutical Composition Comprising the same

The present invention relates to a novel compound having an activity of inhibiting histone deacetylase 6 (HDAC6), an optical isomer thereof or a pharmaceutically acceptable salt thereof, a use thereof for preparation of a drug for treatment, a pharmaceutical composition comprising the same, a treatment method using the composition, and a method for preparing the same. The novel compound, an optical isomer thereof or a pharmaceutically acceptable salt thereof according to the present invention has an activity of inhibiting histone deacetylase 6 (HDAC6), and is effective for preventing or treating HDAC6-related diseases, including infectious diseases; neoplasm; endocrine, nutritional and metabolic diseases; mental and behavior disorders; nerve disorders; eye and adnexa diseases; cardiovascular diseases; respiratory diseases; digestive organ diseases; skin and subcutaneous tissue diseases; musculoskeletal and connective tissue diseases; or congenital malformation, deformation and chromosomal abnormality.COPYRIGHT KIPO 2017